FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022240113> ?p ?o ?g. }

• W2022240113 endingPage "57" @default.
• W2022240113 startingPage "52" @default.
• W2022240113 abstract "Abstract Epigenetic therapy with hypomethylating drugs is now the standard of care in myelodysplastic syndrome (MDS). Response rates remain low, and mechanism-based dose optimization has not been reported. We investigated the clinical and pharmacodynamic results of different dose schedules of decitabine. Adults with advanced MDS or chronic myelomonocytic leukemia (CMML) were randomized to 1 of 3 decitabine schedules: (1) 20 mg/m2 intravenously daily for 5 days; (2) 20 mg/m2 subcutaneously daily for 5 days; and (3) 10 mg/m2 intravenously daily for 10 days. Randomization followed a Bayesian adaptive design. Ninety-five patients were treated (77 with MDS, and 18 with CMML). Overall, 32 patients (34%) achieved a complete response (CR), and 69 (73%) had an objective response by the new modified International Working Group criteria. The 5-day intravenous schedule, which had the highest dose-intensity, was selected as optimal; the CR rate in that arm was 39%, compared with 21% in the 5-day subcutaneous arm and 24% in the 10-day intravenous arm (P &lt; .05). The high dose-intensity arm was also superior at inducing hypomethylation at day 5 and at activating P15 expression at days 12 or 28 after therapy. We conclude that a low-dose, dose-intensity schedule of decitabine optimizes epigenetic modulation and clinical responses in MDS." @default.
• W2022240113 created "2016-06-24" @default.
• W2022240113 creator A5000750846 @default.
• W2022240113 creator A5006104041 @default.
• W2022240113 creator A5008503600 @default.
• W2022240113 creator A5015140142 @default.
• W2022240113 creator A5020254333 @default.
• W2022240113 creator A5026347795 @default.
• W2022240113 creator A5028845635 @default.
• W2022240113 creator A5037784199 @default.
• W2022240113 creator A5053951813 @default.
• W2022240113 creator A5057822243 @default.
• W2022240113 creator A5059555096 @default.
• W2022240113 creator A5061026876 @default.
• W2022240113 creator A5061285204 @default.
• W2022240113 creator A5072600168 @default.
• W2022240113 creator A5084290698 @default.
• W2022240113 creator A5089428686 @default.
• W2022240113 creator A5090435894 @default.
• W2022240113 date "2006-08-01" @default.
• W2022240113 modified "2023-10-18" @default.
• W2022240113 title "Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia" @default.
• W2022240113 cites W1484293540 @default.
• W2022240113 cites W1504303645 @default.
• W2022240113 cites W1997091454 @default.
• W2022240113 cites W2041481720 @default.
• W2022240113 cites W2056502554 @default.
• W2022240113 cites W2081279521 @default.
• W2022240113 cites W2094615848 @default.
• W2022240113 cites W2106401558 @default.
• W2022240113 cites W2106584820 @default.
• W2022240113 cites W2109895173 @default.
• W2022240113 cites W2129510594 @default.
• W2022240113 cites W2145337538 @default.
• W2022240113 cites W2145750252 @default.
• W2022240113 cites W2159104864 @default.
• W2022240113 cites W2159507916 @default.
• W2022240113 cites W2168387971 @default.
• W2022240113 cites W4240220710 @default.
• W2022240113 doi "https://doi.org/10.1182/blood-2006-05-021162" @default.
• W2022240113 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16882708" @default.
• W2022240113 hasPublicationYear "2006" @default.
• W2022240113 type Work @default.
• W2022240113 sameAs 2022240113 @default.
• W2022240113 citedByCount "635" @default.
• W2022240113 countsByYear W20222401132012 @default.
• W2022240113 countsByYear W20222401132013 @default.
• W2022240113 countsByYear W20222401132014 @default.
• W2022240113 countsByYear W20222401132015 @default.
• W2022240113 countsByYear W20222401132016 @default.
• W2022240113 countsByYear W20222401132017 @default.
• W2022240113 countsByYear W20222401132018 @default.
• W2022240113 countsByYear W20222401132019 @default.
• W2022240113 countsByYear W20222401132020 @default.
• W2022240113 countsByYear W20222401132021 @default.
• W2022240113 countsByYear W20222401132022 @default.
• W2022240113 countsByYear W20222401132023 @default.
• W2022240113 crossrefType "journal-article" @default.
• W2022240113 hasAuthorship W2022240113A5000750846 @default.
• W2022240113 hasAuthorship W2022240113A5006104041 @default.
• W2022240113 hasAuthorship W2022240113A5008503600 @default.
• W2022240113 hasAuthorship W2022240113A5015140142 @default.
• W2022240113 hasAuthorship W2022240113A5020254333 @default.
• W2022240113 hasAuthorship W2022240113A5026347795 @default.
• W2022240113 hasAuthorship W2022240113A5028845635 @default.
• W2022240113 hasAuthorship W2022240113A5037784199 @default.
• W2022240113 hasAuthorship W2022240113A5053951813 @default.
• W2022240113 hasAuthorship W2022240113A5057822243 @default.
• W2022240113 hasAuthorship W2022240113A5059555096 @default.
• W2022240113 hasAuthorship W2022240113A5061026876 @default.
• W2022240113 hasAuthorship W2022240113A5061285204 @default.
• W2022240113 hasAuthorship W2022240113A5072600168 @default.
• W2022240113 hasAuthorship W2022240113A5084290698 @default.
• W2022240113 hasAuthorship W2022240113A5089428686 @default.
• W2022240113 hasAuthorship W2022240113A5090435894 @default.
• W2022240113 hasBestOaLocation W20222401131 @default.
• W2022240113 hasConcept C104317684 @default.
• W2022240113 hasConcept C126322002 @default.
• W2022240113 hasConcept C143998085 @default.
• W2022240113 hasConcept C150194340 @default.
• W2022240113 hasConcept C190727270 @default.
• W2022240113 hasConcept C2776012956 @default.
• W2022240113 hasConcept C2776239401 @default.
• W2022240113 hasConcept C2777928532 @default.
• W2022240113 hasConcept C2778461978 @default.
• W2022240113 hasConcept C2780007613 @default.
• W2022240113 hasConcept C2780235182 @default.
• W2022240113 hasConcept C2780817109 @default.
• W2022240113 hasConcept C55493867 @default.
• W2022240113 hasConcept C71924100 @default.
• W2022240113 hasConcept C86803240 @default.
• W2022240113 hasConceptScore W2022240113C104317684 @default.
• W2022240113 hasConceptScore W2022240113C126322002 @default.
• W2022240113 hasConceptScore W2022240113C143998085 @default.
• W2022240113 hasConceptScore W2022240113C150194340 @default.
• W2022240113 hasConceptScore W2022240113C190727270 @default.
• W2022240113 hasConceptScore W2022240113C2776012956 @default.
• W2022240113 hasConceptScore W2022240113C2776239401 @default.

• next